Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

2.

Pre-tibial myxedema: treatment with intralesional corticosteroid.

Ramos LO, Mattos PC, Figueredo GL, Maia AA, Romero SA.

An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):143-6. doi: 10.1590/abd1806-4841.20153651.

3.

Pretibial myxedema as the initial manifestation of Graves' disease.

Georgala S, Katoulis AC, Georgala C, Katoulis EC, Hatziolou E, Stavrianeas NG.

J Eur Acad Dermatol Venereol. 2002 Jul;16(4):380-3.

PMID:
12224697
4.

Pretibial myxedema: pathophysiology and treatment options.

Fatourechi V.

Am J Clin Dermatol. 2005;6(5):295-309. Review.

PMID:
16252929
5.

Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution.

Omohundro C, Dijkstra JW, Camisa C, Bergfeld WF.

Cutis. 1996 Sep;58(3):211-4.

PMID:
8886536
6.

[A woman with red, swollen lower legs].

Siemerink M, van Praag MC.

Ned Tijdschr Geneeskd. 2010;154:A1186. Dutch.

PMID:
20977783
8.

Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases.

Fatourechi V, Pajouhi M, Fransway AF.

Medicine (Baltimore). 1994 Jan;73(1):1-7.

PMID:
8309359
9.

Pretibial mucin. Histologic patterns and clinical correlation.

Somach SC, Helm TN, Lawlor KB, Bergfeld WF, Bass J.

Arch Dermatol. 1993 Sep;129(9):1152-6.

PMID:
8363399
10.

TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.

Chang TC, Wu SL, Hsiao YL, Kuo ST, Chien LF, Kuo YF, Change CC, Chang TJ.

Clin Immunol Immunopathol. 1994 Apr;71(1):113-20.

PMID:
8137554
11.

Unusual locations of localized myxedema in Graves' disease. Report of three cases.

Noppakun N, Bancheun K, Chandraprasert S.

Arch Dermatol. 1986 Jan;122(1):85-8.

PMID:
3753644
12.
13.

Elephantiasis Nostras Verrucosa: a rare thyroid dermopathy in Graves' disease.

Kakati S, Doley B, Pal S, Deka UJ.

J Assoc Physicians India. 2005 Jun;53:571-2.

PMID:
16121817
14.

Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.

Sendhil Kumaran M, Dutta P, Sakia U, Dogra S.

Int J Dermatol. 2015 Aug;54(8):e280-6. doi: 10.1111/ijd.12658. Epub 2015 May 27.

PMID:
26019115
15.

Euthyroid pretibial myxedema.

Chen JJ, Ladenson PW.

Am J Med. 1987 Feb;82(2):318-20.

PMID:
3812528
16.

Pretibial myxedema and high-dose intravenous immunoglobulin treatment.

Antonelli A, Navarranne A, Palla R, Alberti B, Saracino A, Mestre C, Roger P, Agostini S, Baschieri L.

Thyroid. 1994 Winter;4(4):399-408.

PMID:
7711502
17.

Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles.

Vannucchi G, Campi I, Covelli D, Forzenigo L, Beck-Peccoz P, Salvi M.

Thyroid. 2013 May;23(5):626-32. doi: 10.1089/thy.2012.0429.

PMID:
23397966
18.

Graves' dermopathy: responsive with intralesion steroid.

Tarigan TJ, Rihatmadja R, Hutabarat E.

Acta Med Indones. 2014 Apr;46(2):148-9. No abstract available.

19.

Graves' disease presenting as localized myxedema in a thigh donor graft site.

Missner SC, Ramsay EW, Houck HE, Kauffman CL.

J Am Acad Dermatol. 1998 Nov;39(5 Pt 2):846-9.

PMID:
9810913
20.

Successful combined pentoxifylline and intralesional triamcinolone acetonide treatment of severe pretibial myxedema.

Engin B, Gümüşel M, Ozdemir M, Cakir M.

Dermatol Online J. 2007 May 1;13(2):16. No abstract available.

PMID:
17498435

Supplemental Content

Support Center